Publicaciones Imprimir Caravaca-Fontan F, Yandian F, Zand L, Sethi S, Fervenza FC. Antimalarials in Lupus Nephritis: How Strong is the Evidence? Kidney360. 2024 Oct 21 [Epub ahead of print] View PubMed Falde SD, Lal A, Cartin-Ceba R, Mertz LE, Fervenza FC, Zand L, Koster MJ, Warrington KJ, Lee AS, Aslam N, Abril A, Specks U. Treatment of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis With Diffuse Alveolar Hemorrhage With Avacopan. ACR Open Rheumatol. 2024 Oct; 6 (10):707-716 Epub 2024 July 30 View PubMed Casal Moura M, Zubidat D, Liebana MP, Sethi S, Soler MJ, Zand L, Dos Santos FG, Nardelli L, Leon-Roman J, Sousa C, Warrington KJ, Specks U, Fervenza FC. Predictive Factors of Renal Recovery and Progression to End-Stage Kidney Disease in Patients With Antineutrophil Cytoplasmic Autoantibody-Associated Vasculitis With Severe Kidney Disease. Kidney Int Rep. 2024 May; 9 (5):1284-1297 Epub 2024 Mar 06 View PubMed Barbour SJ, Coppo R, Er L, Pillebout E, Russo ML, Alpers CE, Fogo AB, Ferrario F, Jennette JC, Roberts ISD, Cook HT, Ding J, Su B, Zhong X, Fervenza FC, Zand L, Peruzzi L, Lucchetti L, Katafuchi R, Shima Y, Yoshikawa N, Ichikawa D, Suzuki Y, Murer L, Wyatt RJ, Park C, Nelson RD, Narus JH, Wenderfer S, Geetha D, Daugas E, Monteiro RC, Nakatani S, Mastrangelo A, Nuutinen M, Koskela M, Weber LT, Hackl A, Pohl M, Pecoraro C, Tsuboi N, Yokoo T, Takafumi I, Fujimoto S, Conti G, Santoro D, Materassi M, Zhang H, Shi S, Liu ZH, Tesar V, Maixnerova D, Avila-Casado C, Bajema I, Barreca A, Becker JU, Comstock JM, Cornea V, Eldin K, Hernandez LH, Hou J, Joh K, Lin M, Messias N, Muda AO, Pagni F, Diomedi-Camassei F, Tokola H, D'Armiento M, Seidl M, Rosenberg A, Sannier A, Soares MF, Wang S, Zeng C, Haas M. Histologic and Clinical Factors Associated with Kidney Outcomes in IgA Vasculitis Nephritis. Clin J Am Soc Nephrol. 2024 Apr 1; 19 (4):438-451 Epub 2024 Jan 23 View PubMed Sy-Go JPT, Moubarak S, Vaughan LE, Klomjit N, Viehman JK, Fervenza FC, Zand L. Monoclonal Gammopathy and Its Association with Progression to Kidney Failure and Mortality in Patients with CKD. Clin J Am Soc Nephrol. 2024 Mar 1; 19 (3):319-328 Epub 2023 Nov 10 View PubMed Radhakrishnan Y, Zand L, Sethi S, Fervenza FC. Membranous nephropathy treatment standard. Nephrol Dial Transplant. 2024 Feb 28; 39 (3):403-413 View PubMed Miao J, Duriseti P, Radhakrishnan Y, Vaughan L, Fervenza FC, Zand L. Mycophenolate Mofetil and Steroid for Treatment of Patients With IgA Nephropathy. Kidney Int Rep. 2024 Jan; 9 (1):182-185 Epub 2023 Oct 20 View PubMed Sethi S, Beck LH Jr, Glassock RJ, Haas M, De Vriese AS, Caza TN, Hoxha E, Lambeau G, Tomas NM, Madden B, Debiec H, D'Agati VD, Alexander MP, Amer H, Appel GB, Barbour SJ, Caravaca-Fontan F, Cattran DC, Casal Moura M, D'Avila DO, Eick RG, Garovic VD, Greene EL, Herrera Hernandez LP, Jennette JC, Lieske JC, Markowitz GS, Nath KA, Nasr SH, Nast CC, Pani A, Praga M, Remuzzi G, Rennke HG, Ruggenenti P, Roccatello D, Soler MJ, Specks U, Stahl RAK, Singh RD, Theis JD, Velosa JA, Wetzels JFM, Winearls CG, Yandian F, Zand L, Ronco P, Fervenza FC. Mayo Clinic consensus report on membranous nephropathy: proposal for a novel classification. Kidney Int. 2023 Dec; 104(6):1092-1102. Epub 2023 Oct 05. View PubMed Zand L, Fervenza FC, Coppo R. Microscopic hematuria as a risk factor for IgAN progression: considering this biomarker in selecting and monitoring patients. Clin Kidney J. 2023 Dec; 16 (Suppl 2):ii19-ii27 Epub 2023 Dec 04 View PubMed Sethi S, Beck LH Jr, Glassock RJ, Haas M, De Vriese AS, Caza TN, Hoxha E, Lambeau G, Tomas NM, Madden B, Debiec H, D'Agati VD, Alexander MP, Amer H, Appel GB, Barbour SJ, Caravaca-Fontan F, Cattran DC, Casal Moura M, D'Avila DO, Eick RG, Garovic VD, Greene EL, Herrera Hernandez LP, Jennette JC, Lieske JC, Markowitz GS, Nath KA, Nasr SH, Nast CC, Pani A, Praga M, Remuzzi G, Rennke HG, Ruggenenti P, Roccatello D, Soler MJ, Specks U, Stahl RAK, Singh RD, Theis JD, Velosa JA, Wetzels JFM, Winearls CG, Yandian F, Zand L, Ronco P, Fervenza FC. Mayo Clinic Consensus Report on Membranous Nephropathy: Proposal for a Novel Classification. Mayo Clin Proc. 2023 Nov; 98(11):1671-1684. Epub 2023 Oct 05. View PubMed Lieske JC, Leung N, Erickson SB, Garg P, Rao P, Jain N, Thomas L, Li T, Levin A, Sethi S, Barbour SJ, Fervenza FC, Induruwage D, Brenchley PE, Rovin B, Hladunewich MA, Reich HN, Lafayette R, Aslam N, Appel GB, Zand L, Kiryluk K, Liu L, Cattran DC, MENTOR Trial Investigators. Anti-PLA2R Antibody Levels and Clinical Risk Factors for Treatment Nonresponse in Membranous Nephropathy. Clin J Am Soc Nephrol. 2023 Oct 1; 18 (10):1283-1293 Epub 2023 July 20 View PubMed Zand L, Fervenza FC. Anti-CD20 should be the first-line treatment in high-risk membranous nephropathy. Clin Kidney J. 2023 Sep; 16 (9):1420-1425 Epub 2023 Apr 10 View PubMed Klomjit N, Zand L, Cornell LD, Alexander MP. COVID-19 and Glomerular Diseases. Kidney Int Rep. 2023 Jun; 8 (6):1137-1150 Epub 2023 Mar 27 View PubMed Hocaoglu M, Valenzuela-Almada MO, Dabit JY, Osei-Onomah SA, Chevet B, Giblon RE, Zand L, Fervenza FC, Helmick CG, Crowson CS, Duarte-Garcia A. Incidence, Prevalence, and Mortality of Lupus Nephritis: A Population-Based Study Over Four Decades Using the Lupus Midwest Network. Arthritis Rheumatol. 2023 Apr; 75 (4):567-573 Epub 2023 Jan 30 View PubMed Casal Moura M, Crowson CS, Specks U, Warrington KJ, Zand L, Sethi S, Fervenza FC. PLEX in AAV-GN: insights from the meta-analysis results and impact on remission induction treatment recommendations. Clin Kidney J. 2023 Mar; 16(3):432-436. Epub 2022 Oct 08. View PubMed Radhakrishnan Y, Zand L. New Onset Glomerular Disease Post-COVID-19 Vaccination: Is There a Link? Kidney360 2023 Mar 1; 4 (3):294-296 View PubMed Casal Moura M, Specks U, Tehranian S, Sethi S, Zubidat D, Nardelli L, Dos Santos FG, Sousa C, Leon-Roman J, Bobart SA, Greene E, Zand L, Fervenza FC. Maintenance of Remission and Risk of Relapse in Myeloperoxidase-Positive ANCA-Associated Vasculitis with Kidney Involvement. Clin J Am Soc Nephrol. 2023 Jan 1; 18 (1):47-59 View PubMed Casal Moura M, Specks U, Tehranian S, Sethi S, Zubidat D, Nardelli L, Dos Santos FG, Sousa C, Leon-Roman J, Bobart SA, Greene E, Zand L, Fervenza FC. Maintenance of remission and risk of relapse in myeloperoxidase-positive ANCA-associated vasculitis with kidney involvement. Clinical Journal of the American Society of Nephrology: CJASN. 2023; 18 (1):47-59 Moubarak S, Herrera Hernandez LP, Cornell LD, Caza T, Zand L. Relapsing and Remitting Proliferative Glomerulonephritis With Monoclonal Immunoglobulin Deposits in Association With Infection and Vaccination: A Case Report. Kidney Med. 2023 Jan; 5 (1):100575 Epub 2022 Nov 18 View PubMed Miao J, Nasr SH, Zand L, Kattah AG. A Pregnant Woman With New-Onset Hypertension and Acute Kidney Injury. Kidney Int Rep. 2022 Apr; 7 (4):924-929 Epub 2021 Dec 31 View PubMed Klomjit N, Zand L. Catastrophic kidney infarction. Kidney Int. 2022 Jan; 101 (1):189 View PubMed Bobart SA, Han H, Tehranian S, De Vriese AS, Roman JCL, Sethi S, Zand L, Andrades Gomez C, Giesen CD, Soler MJ, Bomback AS, Fervenza FC. Noninvasive Diagnosis of PLA2R-Associated Membranous Nephropathy: A Validation Study. Clin J Am Soc Nephrol. 2021 Dec; 16 (12):1833-1839 Epub 2021 Nov 15 View PubMed Klomjit N, Alexander MP, Fervenza FC, Zoghby Z, Garg A, Hogan MC, Nasr SH, Minshar MA, Zand L. COVID-19 Vaccination and Glomerulonephritis. Kidney Int Rep. 2021 Dec; 6(12):2969-2978. Epub 2021 Oct 06. View PubMed Klomjit N, Zand L. Rituximab Is Preferable to Cyclophosphamide for Treatment of Membranous Nephropathy: COMMENTARY. Kidney360. 2021 Nov 25; 2 (11):1702-1705 Epub 2021 Apr 19 View PubMed Heybeli C, Erickson SB, Fervenza FC, Hogan MC, Zand L, Leung N. Comparison of treatment options in adults with frequently relapsing or steroid-dependent minimal change disease. Nephrol Dial Transplant. 2021 Sep 27; 36 (10):1821-1827 View PubMed Miao J, Pinto E Vairo F, Hogan MC, Erickson SB, El Ters M, Bentall AJ, Kukla A, Greene EL, Hernandez LH, Sethi S, Lazaridis KN, Pichurin PN, Lisi E, Prochnow CA, Zand L, Fervenza FC. Identification of Genetic Causes of Focal Segmental Glomerulosclerosis Increases With Proper Patient Selection. Mayo Clin Proc. 2021 Sep; 96(9):2342-2353. Epub 2021 Jun 11. View PubMed Zand L, Rajkumar SV, Leung N, Sethi S, El Ters M, Fervenza FC. Safety and Efficacy of Daratumumab in Patients with Proliferative GN with Monoclonal Immunoglobulin Deposits. J Am Soc Nephrol. 2021 May 3; 32 (5):1163-1173 Epub 2021 Mar 08 View PubMed Bobart SA, Alexander MP, Shawwa K, Vaughan LE, Ghamrawi R, Sethi S, Cornell L, Glassock RJ, Fervenza FC, Zand L. The association of microhematuria with mesangial hypercellularity, endocapillary hypercellularity, crescent score and renal outcomes in immunoglobulin A nephropathy. Nephrol Dial Transplant. 2021 Apr 26; 36 (5):840-847 View PubMed Gauckler P, Shin JI, Alberici F, Audard V, Bruchfeld A, Busch M, Cheung CK, Crnogorac M, Delbarba E, Eller K, Faguer S, Galesic K, Griffin S, van den Hoogen MWF, Hruskova Z, Jeyabalan A, Karras A, King C, Kohli HS, Mayer G, Maas R, Muto M, Moiseev S, Odler B, Pepper RJ, Quintana LF, Radhakrishnan J, Ramachandran R, Salama AD, Schonermarck U, Segelmark M, Smith L, Tesar V, Wetzels J, Willcocks L, Windpessl M, Zand L, Zonozi R, Kronbichler A, RITERM study group. Rituximab in Membranous Nephropathy. Kidney Int Rep. 2021 Apr; 6 (4):881-893 Epub 2021 Jan 13 View PubMed Specks U, Fussner LA, Cartin-Ceba R, Casal Moura M, Zand L, Fervenza FC. Plasma exchange for the management of ANCA-associated vasculitis: the con position. Nephrol Dial Transplant. 2021 Jan 25; 36(2):231-236. View PubMed Erickson SB, Zand L, Nasr SH, Alexander MP, Leung N, Drosou ME, Fervenza FC. Treatment of fibrillary glomerulonephritis with rituximab: a 12-month pilot study. Nephrol Dial Transplant. 2021 Jan 1; 36 (1):104-110 View PubMed Pinto E Vairo F, Prochnow C, Kemppainen JL, Lisi EC, Steyermark JM, Kruisselbrink TM, Pichurin PN, Dhamija R, Hager MM, Albadri S, Cornell LD, Lazaridis KN, Klee EW, Senum SR, El Ters M, Amer H, Baudhuin LM, Moyer AM, Keddis MT, Zand L, Sas DJ, Erickson SB, Fervenza FC, Lieske JC, Harris PC, Hogan MC. Genomics Integration Into Nephrology Practice. Kidney Med. 2021 Sep-Oct; 3(5):785-798. Epub 2021 Jun 29. View PubMed Thorsteinsdottir B, Hickson LJ, Giblon R, Pajouhi A, Connell N, Branda M, Vasdev AK, McCoy RG, Zand L, Tangri N, Shah ND. Validation of prognostic indices for short term mortality in an incident dialysis population of older adults >75. PLoS One. 2021; 16 (1):e0244081 Epub 2021 Jan 20 View PubMed Klomjit N, Fervenza FC, Zand L. Successful Treatment of Patients With Refractory PLA2R-Associated Membranous Nephropathy With Obinutuzumab: A Report of 3 Cases. Am J Kidney Dis. 2020 Dec; 76 (6):883-888 Epub 2020 Apr 18 View PubMed Gauckler P, Shin JI, Alberici F, Audard V, Bruchfeld A, Busch M, Cheung CK, Crnogorac M, Delbarba E, Eller K, Faguer S, Galesic K, Griffin S, Hruskova Z, Jeyabalan A, Karras A, King C, Kohli HS, Maas R, Mayer G, Moiseev S, Muto M, Odler B, Pepper RJ, Quintana LF, Radhakrishnan J, Ramachandran R, Salama AD, Segelmark M, Tesar V, Wetzels J, Willcocks L, Windpessl M, Zand L, Zonozi R, Kronbichler A, RITERM study group. Rituximab in adult minimal change disease and focal segmental glomerulosclerosis - What is known and what is still unknown? Autoimmun Rev. 2020 Nov; 19 (11):102671 Epub 2020 Sept 15 View PubMed Casal Moura M, Irazabal MV, Eirin A, Zand L, Sethi S, Borah BJ, Winters JL, Moriarty JP, Cartin-Ceba R, Berti A, Baqir M, Thompson GE, Makol A, Warrington KJ, Thao V, Specks U, Fervenza FC. Efficacy of Rituximab and Plasma Exchange in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis with Severe Kidney Disease. J Am Soc Nephrol. 2020 Nov; 31 (11):2688-2704 Epub 2020 Aug 21 View PubMed El Ters M, Bobart SA, Cornell LD, Leung N, Bentall A, Sethi S, Fidler M, Grande J, Hernandez LH, Cosio FG, Zand L, Amer H, Fervenza FC, Nasr SH, Alexander MP. Recurrence of DNAJB9-Positive Fibrillary Glomerulonephritis After Kidney Transplantation: A Case Series. Am J Kidney Dis. 2020 Oct; 76 (4):500-510 Epub 2020 May 12 View PubMed Klomjit N, Leung N, Fervenza F, Sethi S, Zand L. Rate and Predictors of Finding Monoclonal Gammopathy of Renal Significance (MGRS) Lesions on Kidney Biopsy in Patients with Monoclonal Gammopathy. J Am Soc Nephrol. 2020 Oct; 31 (10):2400-2411 Epub 2020 Aug 03 View PubMed Klomjit N, Alexander MP, Zand L. Fibrillary Glomerulonephritis and DnaJ Homolog Subfamily B Member 9 (DNAJB9). Kidney360. 2020 Sep 24; 1 (9):1002-1013 Epub 2020 July 08 View PubMed Herrmann SM, Alexander MP, Romero MF, Zand L. Renal Tubular Acidosis and Immune Checkpoint Inhibitor Therapy: An Immune-Related Adverse Event of PD-1 Inhibitor-A Report of 3 Cases. Kidney Med. 2020 Sep-Oct; 2 (5):657-662 Epub 2020 Aug 11 View PubMed Sethi S, Nast CC, D'Agati VD, Fervenza FC, Glassock RJ, Stokes MB, De Vriese AS, Appel GB, Chang A, Cosio F, Herrera Hernandez L, Markowitz GS, Kumar SK, Alexander MP, Amer H, Murray D, Nasr SH, Leung N, Pani A, Picken MM, Ravindran A, Roccatello D, Ronco P, Royal V, Smith KD, Wechalekar AD, Wetzels J, Zand L, Zhang P, Haas M. Standardized reporting of monoclonal immunoglobulin-associated renal diseases: recommendations from a Mayo Clinic/Renal Pathology Society Working Group. Kidney Int. 2020 Aug; 98 (2):310-313 Epub 2020 Apr 23 View PubMed Miao J, Qian Q, Zand L. Long-Standing Hypokalemia and Lactic Acidosis as the Primary Presentation of Mitochondrial Myopathy. Kidney Int Rep. 2020 May; 5 (5):742-745 Epub 2020 Feb 05 View PubMed Klomjit N, Zand L. Acquired thoracic kidney. Kidney Int. 2020 Apr; 97 (4):811 View PubMed Zand L, Canetta P, Lafayette R, Aslam N, Jan N, Sethi S, Fervenza FC. An Open-Label Pilot Study of Adrenocorticotrophic Hormone in the Treatment of IgA Nephropathy at High Risk of Progression. Kidney Int Rep. 2020 Jan; 5 (1):58-65 Epub 2019 Oct 31 View PubMed Sathick IJ, Zand L, Nasr SH, Leung N. Corticosteroid therapy alone for the treatment of C3 glomerulonephritis in association with monoclonal gammopathy. Clin Nephrol. 2019 Feb; 91 (2):79-86 View PubMed Bobart SA, De Vriese AS, Pawar AS, Zand L, Sethi S, Giesen C, Lieske JC, Fervenza FC. Noninvasive diagnosis of primary membranous nephropathy using phospholipase A2 receptor antibodies. Kidney Int. 2019 Feb; 95 (2):429-438 View PubMed Higgins L, Nasr SH, Said SM, Kapoor P, Dingli D, King RL, Rajkumar SV, Kyle RA, Kourelis T, Gertz MA, Dispenzieri A, Lacy MQ, Buadi FK, Ansell SM, Gonsalves WI, Thompson CA, Fervenza FC, Zand L, Hwa YL, Jevremovic D, Shi M, Leung N. Kidney Involvement of Patients with Waldenstrom Macroglobulinemia and Other IgM-Producing B Cell Lymphoproliferative Disorders. Clin J Am Soc Nephrol. 2018 Jul 6; 13 (7):1037-1046 Epub 2018 May 30 View PubMed Lepori N, Zand L, Sethi S, Fernandez-Juarez G, Fervenza FC. Clinical and pathological phenotype of genetic causes of focal segmental glomerulosclerosis in adults. Clin Kidney J. 2018 Apr; 11 (2):179-190 Epub 2018 Jan 09 View PubMed Hommos MS, De Vriese AS, Alexander MP, Sethi S, Vaughan L, Zand L, Bharucha K, Lepori N, Rule AD, Fervenza FC. The Incidence of Primary vs Secondary Focal Segmental Glomerulosclerosis: A Clinicopathologic Study. Mayo Clin Proc. 2017 Dec; 92 (12):1772-1781 Epub 2017 Oct 27 View PubMed Zand L, Kumar R. The Use of Vitamin D Metabolites and Analogues in the Treatment of Chronic Kidney Disease. Endocrinol Metab Clin North Am. 2017 Dec; 46 (4):983-1007 Epub 2017 Sept 29 View PubMed Gilani SI, Anderson UD, Jayachandran M, Weissgerber TL, Zand L, White WM, Milic N, Suarez Gonzalez ML, Vallapureddy RR, Naav A, Erlandsson L, Lieske JC, Grande JP, Nath KA, Hansson SR, Garovic VD. Urinary Extracellular Vesicles of Podocyte Origin and Renal Injury in Preeclampsia. J Am Soc Nephrol. 2017 Nov; 28 (11):3363-3372 Epub 2017 July 20 View PubMed Kwon SH, Woollard JR, Saad A, Garovic VD, Zand L, Jordan KL, Textor SC, Lerman LO. Elevated urinary podocyte-derived extracellular microvesicles in renovascular hypertensive patients. Nephrol Dial Transplant. 2017 May 1; 32 (5):800-807 View PubMed Sethi S, Zand L, De Vriese AS, Specks U, Vrana JA, Kanwar S, Kurtin P, Theis JD, Angioi A, Cornell L, Fervenza FC. Complement activation in pauci-immune necrotizing and crescentic glomerulonephritis: results of a proteomic analysis. Nephrol Dial Transplant. 2017 Jan 1; 32 (suppl_1):i139-i145 View PubMed Zand L, Glassock RJ, De Vriese AS, Sethi S, Fervenza FC. What are we missing in the clinical trials of focal segmental glomerulosclerosis? Nephrol Dial Transplant. 2017 Jan 1; 32 (suppl_1):i14-i21 View PubMed Kourelis TV, Nasr SH, Dispenzieri A, Kumar SK, Gertz MA, Fervenza FC, Buadi FK, Lacy MQ, Erickson SB, Cosio FG, Kapoor P, Lust JA, Hayman SR, Rajkumar V, Zeldenrust SR, Russell SJ, Dingli D, Lin Y, Gonsalves W, Lorenz EC, Zand L, Kyle RA, Leung N. Outcomes of patients with renal monoclonal immunoglobulin deposition disease. Am J Hematol. 2016 Nov; 91 (11):1123-1128 Epub 2016 Aug 29 View PubMed Zand L, Torres VE, Larson TS, King BF, Sethi S, Bergstralh EJ, Angioi A, Fervenza FC. Renal hemodynamic effects of the HMG-CoA reductase inhibitors in autosomal dominant polycystic kidney disease. Nephrol Dial Transplant. 2016 Aug; 31 (8):1290-5 Epub 2015 Nov 27 View PubMed Kittanamongkolchai W, Cheungpasitporn W, Zand L. Efficacy and safety of adrenocorticotropic hormone treatment in glomerular diseases: a systematic review and meta-analysis. Clin Kidney J. 2016 Jun; 9 (3):387-96 Epub 2016 May 26 View PubMed Wu M, Wang D, Zand L, Harris PC, White WM, Garovic VD, Kermott CA. Pregnancy outcomes in autosomal dominant polycystic kidney disease: a case-control study. J Matern Fetal Neonatal Med. 2016 Mar; 29 (5):807-12 Epub 2015 Mar 10 View PubMed Zand L, Monaghan M, Griffin BR, Wagner SJ, Criaci IM, Kamal A, Raissian Y, Grande JP, Lim KG, Garovic VD. The role of type i hypersensitivity reaction and ige-mediated mast cell activation in acute interstitial nephritis. Clin Nephrol. 2015 Sep; 84(3):138-44. View PubMed Cheungpasitporn W, Zand L, Dillon JJ, Qian Q, Leung N. Lactate clearance and metabolic aspects of continuous high-volume hemofiltration. Clin Kidney J. 2015 Aug; 8 (4):374-7 Epub 2015 June 17 View PubMed Zand L, Nasr SH, Gertz MA, Dispenzieri A, Lacy MQ, Buadi FK, Kumar S, Kyle RA, Fervenza FC, Sethi S, Dingli D, Rajkumar SV, Kapoor P, McCurdy A, Leung N. Clinical and prognostic differences among patients with light chain deposition disease, myeloma cast nephropathy and both. Leuk Lymphoma. 2015; 56 (12):3357-64 Epub 2015 May 12 View PubMed Sethi S, Zand L, Nasr SH, Glassock RJ, Fervenza FC. Focal and segmental glomerulosclerosis: clinical and kidney biopsy correlations. Clin Kidney J. 2014 Dec; 7 (6):531-7 Epub 2014 Sept 28 View PubMed Zand L, Fervenza FC. Does tonsillectomy have a role in the treatment of patients with immunoglobulin A nephropathy? Nephrol Dial Transplant. 2014 Aug; 29(8):1456-9. Epub 2014 Apr 10. View PubMed Zand L, Williams A, Babovic-Vuksanovic D, Nwoko R, Cornell L, Garovic V. The Case | Renal dysfunction in a pregnant patient with IgA nephropathy. Kidney Int. 2014 Jun; 85(6):1477-8. View PubMed Zand L, Lorenz EC, Cosio FG, Fervenza FC, Nasr SH, Gandhi MJ, Smith RJ, Sethi S. Clinical findings, pathology, and outcomes of C3GN after kidney transplantation. J Am Soc Nephrol. 2014 May; 25 (5):1110-7 Epub 2013 Dec 19 View PubMed Zand L, Fervenza FC, Nasr SH, Sethi S. Membranoproliferative glomerulonephritis associated with autoimmune diseases. J Nephrol. 2014 Apr; 27 (2):165-71 Epub 2014 Feb 06 View PubMed Zand L, Specks U, Sethi S, Fervenza FC. Treatment of ANCA-associated vasculitis: new therapies and a look at old entities. Adv Chronic Kidney Dis. 2014 Mar; 21: (2)182-93. View PubMed Moua T, Zand L, Hartman RP, Hartman TE, Qin D, Peikert T, Qian Q. Radiologic and clinical bronchiectasis associated with autosomal dominant polycystic kidney disease. PLoS One. 2014; 9 (4):e93674 Epub 2014 Apr 18 View PubMed Jaffer Sathick I, Zand L, Kamal AN, Norby SM, Garovic VD. Acute interstitial nephritis: etiology, pathogenesis, diagnosis, treatment and prognosis. Nephrology Reviews. 2013 Nov 28; 5(1):13-20. Zand L, Kattah A, Fervenza FC, Smith RJ, Nasr SH, Zhang Y, Vrana JA, Leung N, Cornell LD, Sethi S. C3 glomerulonephritis associated with monoclonal gammopathy: a case series. Am J Kidney Dis. 2013 Sep; 62 (3):506-14 Epub 2013 Apr 26 View PubMed Franco Palacios CR, Lieske JC, Wadei HM, Rule AD, Fervenza FC, Voskoboev N, Garovic VD, Zand L, Stegall MD, Cosio FG, Amer H. Urine but not serum soluble urokinase receptor (suPAR) may identify cases of recurrent FSGS in kidney transplant candidates. Transplantation. 2013 Aug 27; 96 (4):394-9 View PubMed Sethi S, Fervenza FC, Zhang Y, Zand L, Meyer NC, Borsa N, Nasr SH, Smith RJ. Atypical postinfectious glomerulonephritis is associated with abnormalities in the alternative pathway of complement. Kidney Int. 2013 Feb; 83 (2):293-9 Epub 2012 Dec 12 View PubMed Sethi S, Fervenza FC, Zhang Y, Zand L, Meyer NC, Borsa N, Nasr, S, Smith R. Atypical post-infectious glomerulonephritis is associated with abnormalities in the alternative pathway of complement. Kidney International 82 (. 2013; 3):293-9. Zand L, Muriithi A, Nelsen E, Franco PM, Greene EL, Qian Q, El-Zoghby ZM. Severe anion gap metabolic acidosis from acetaminophen use secondary to 5-oxoproline (pyroglutamic acid) accumulation. Am J Med Sci. 2012 Dec; 344(6):501-4. View PubMed Sethi S, Fervenza FC, Zhang Y, Zand L, Vrana JA, Nasr SH, Theis JD, Dogan A, Smith RJ. C3 glomerulonephritis: clinicopathological findings, complement abnormalities, glomerular proteomic profile, treatment, and follow-up. Kidney Int. 2012 Aug; 82 (4):465-73 View PubMed Lee BJ, Zand L, Manek NJ, Hsiao LL, Babovic-Vuksanovic D, Wylam ME, Qian Q. Physical therapy-induced rhabdomyolysis and acute kidney injury associated with reduced activity of muscle lactate dehydrogenase A. Arthritis Care Res (Hoboken). 2011 Dec; 63(12):1782-6. View PubMed Franco Palacios C, Keddis MT, Qin D, Zand L, Li G, Wang X, Cartin-Ceba R, Hartman RP, Qian Q. Acute Kidney Injury in ADPKD Patients with Pneumonia. Int J Nephrol. 2011; 2011:617904 Epub 2011 July 25 View PubMed Zand L, Hoffman SJ, Nyman MA. 74-year-old woman with new-onset myoclonus. Mayo Clin Proc. 2010 Oct; 85 (10):955-8 View PubMed Sethi S, Zand L, Leung N, Smith RJ, Jevremonic D, Herrmann SS, Fervenza FC. Membranoproliferative glomerulonephritis secondary to monoclonal gammopathy. Clin J Am Soc Nephrol. 2010 May; 5 (5):770-82 Epub 2010 Feb 25 View PubMed Zand L, McKian KP, Qian Q. Gabapentin toxicity in patients with chronic kidney disease: a preventable cause of morbidity. Am J Med. 2010 Apr; 123 (4):367-73 View PubMed Zand L, Hoffman S, Nyman MA. 74-year-old female with new-onset myoclonus. Mayo Clinic Proceedings 85 (10); 955-8. 2010. Zand L, Ryu JK, McLarnon JG. Induction of angiogenesis in beta-amyloid peptide-injected rat hippocampus. Neuroreport (2): 129-32. 2005; Neuroreport. 2005:16. Zand L, Qiang F, Roskelley CD, Leung PC, Auersperg N. Differential effects of cellular fibronectin and plasma fibronectin on ovarian cancer cell adhesion, migration, and invasion. In Vitro Cellular & Developmental Biology - Animal 39 (. 2003; 3-4:178-82. PST-20540741 Inicio Publicaciones